4.7 Article

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study

Eric Yuk Fai Wan et al.

Summary: The study evaluated the risk of Bell's palsy after vaccination with BNT162b2 and CoronaVac, finding an increased risk of Bell's palsy following CoronaVac vaccination. However, the overall benefits and protective effects of the inactivated COVID-19 vaccine far outweigh the risk of this generally self-limiting adverse event.

LANCET INFECTIOUS DISEASES (2022)

Letter Rheumatology

Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'

Serena Bugatti et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Meeting Abstract Rheumatology

5 YEARS FOLLOW-UP OF PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TREAT-TO-TARGET STRATEGY. PRELIMINARY RESULTS

P. Tremaskina et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Rheumatology

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer et al.

Summary: Vaccination with mRNA BNT162b2 vaccine showed reduced immunogenicity in patients with AIIRD compared to the general population, with risk factors including older age and treatment with glucocorticoids, rituximab, mycophenolate mofetil (MMF), and abatacept. However, most patients maintained stable disease activity post-vaccination.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Letter Rheumatology

Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection

Chokan Baimukhamedov

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Article Biochemistry & Molecular Biology

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Ana C. Medeiros-Ribeiro et al.

Summary: In a large prospective phase 4 trial, vaccination with CoronaVac, an inactivated SARS-CoV-2 vaccine, elicited significantly lower virus-specific IgG antibodies and neutralizing antibodies in patients with autoimmune rheumatic diseases than in age- and sex-matched healthy control trial participants.

NATURE MEDICINE (2021)

Article Biotechnology & Applied Microbiology

Reactive arthritis after COVID-19 vaccination

Qi-jun An et al.

Summary: Reactive arthritis (ReA) following COVID-19 vaccination is rare but the benefits of vaccination outweigh potential risks. Future attention should focus on identifying individuals at higher risk for developing autoimmune diseases after COVID-19 vaccination and exploring more versatile and safer vaccines.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Article Medicine, General & Internal

Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation

Wallis C. Y. Lau et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Psychiatry

Association of Risk of Suicide Attempts With Methylphenidate Treatment

Kenneth K. C. Man et al.

JAMA PSYCHIATRY (2017)

Review Rheumatology

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

Josef S. Smolen et al.

NATURE REVIEWS RHEUMATOLOGY (2015)